IntroMedic Co., Ltd. (KOSDAQ:150840)

IntroMedic Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,450	-	223,669	223,669	251,198	103,519
Market Cap Growth	-91.59%	-	-	-10.96%	142.66%	37.35%
Enterprise Value	7,535	-	232,244	225,561	256,952	104,342
Last Close Price	150.00	-	5850.00	5850.00	6570.00	3300.00
PS Ratio	0.64	-	22.42	22.64	31.92	17.36
PB Ratio	1.46	-	28.98	13.56	5.61	4.60
P/TBV Ratio	1.45	-	29.19	15.21	6.13	4.69
EV/Sales Ratio	0.75	-	23.28	22.83	32.65	17.50
EV/FCF Ratio	-26.43	-	-	-	-	-
Debt / Equity Ratio	0.50	0.43	0.99	0.66	0.18	0.12
Asset Turnover	0.97	0.74	0.40	0.22	0.18	0.19
Inventory Turnover	0.98	0.98	1.45	1.62	1.52	1.33
Quick Ratio	0.81	0.94	0.49	1.00	0.75	1.03
Current Ratio	2.00	2.25	0.99	1.28	3.27	2.17
Return on Equity (ROE)	-24.68%	-84.30%	-55.41%	-76.15%	-67.44%	-38.46%
Return on Assets (ROA)	-11.04%	-8.81%	-9.31%	-4.96%	-12.07%	-10.58%
Return on Invested Capital (ROIC)	-32.20%	-19.33%	-22.84%	-10.71%	-25.26%	-27.78%
Return on Capital Employed (ROCE)	-35.20%	-28.10%	-36.80%	-18.70%	-18.30%	-23.40%
Earnings Yield	-21.46%	-	-3.05%	-10.40%	-8.96%	-6.98%
FCF Yield	-4.42%	-	-1.89%	-2.44%	-1.59%	-3.93%
Buyback Yield / Dilution	-5.88%	-9.24%	-0.05%	-8.26%	-27.72%	-30.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.